跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salbulife - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salbulife
Approved
STANDARD
Salbulife
Eurolife Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c675c7a392871e11
Company
Eurolife Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c675c7a392871e11
Drug Approval Philippines Name
Salbulife
Product Name
Salbulife
Registration Number
DRP-11976
Brand Name
Salbulife
Generic Name
Salbutamol (as sulfate)
Dosage Form
Solution for Inhalation
Dosage Strength
1mg/mL (2.5mg/2.5mL)
Manufacturer
Eurolife Healthcare Pvt. Ltd.
Importer
S.M.H.P. Marketing & Consultancy
Distributor
S.M.H.P. Marketing & Consultancy
Issuance Date
24 January 2024
Expiry Date
27 December 2028
Pharmacologic Category
Selective beta-2-adrenoreceptor agonist
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c675c7a392871e11
Type
Standard
Back to Philippines FDA Approvals